menu
    • menu

    Company profile for Satellos Bioscience

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Satellos is a biotechnology company built on groundbreaking science focused on skeletal muscle regeneration. The company's overarching vision is to create and advance medicines that harness the body's natural capacity for self-repair, providing a novel approach to address severe muscle disorders. Leveraging their proprietary MyoReGenX™ discovery platform, Satellos has uncovered significant insights into the regulation of mus...
    Satellos is a biotechnology company built on groundbreaking science focused on skeletal muscle regeneration. The company's overarching vision is to create and advance medicines that harness the body's natural capacity for self-repair, providing a novel approach to address severe muscle disorders. Leveraging their proprietary MyoReGenX™ discovery platform, Satellos has uncovered significant insights into the regulation of muscle cells. Their discoveries extend across a spectrum of conditions, from genetic disorders like Duchenne muscular dystrophy to age-related debilitations.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Satellos BioscienceCanada Flag
    Country
    Country
    Canada
    Address
    Address
    200 Bay Street, Suite 2800, Toronto, ON M5J 2J1
    Telephone
    Telephone
    +1 6476601780
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://satellos.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/satellos-bioscience-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/SatellosBio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Products Expo

    Natural Products Expo

    Not Confirmed

    envelop Contact Supplier

    Natural Products Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Satellos To Present At 2026 Muscular Dystrophy Conference
    Satellos To Present At 2026 Muscular Dystrophy Conference

    24 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-24/satellos-announces-upcoming-oral-and-poster-presentations-at-the-2026-muscular-dystrophy-association

    PHARMIWEB
    24 Feb 2026
    Share Share
    Satellos Hosts Virtual KOL Event on SAT-3247 for DMD
    Satellos Hosts Virtual KOL Event on SAT-3247 for DMD

    18 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260218704143/en/Satellos-to-Host-Virtual-KOL-Event-on-SAT-3247-in-Duchenne-Muscular-Dystrophy

    BUSINESSWIRE
    18 Feb 2026
    Share Share
    Satellos To Participate In Upcoming Investor Conferences
    Satellos To Participate In Upcoming Investor Conferences

    17 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-17/satellos-to-participate-in-upcoming-investor-conferences

    PHARMIWEB
    17 Feb 2026
    Share Share
    Satellos Doses First Patient in Phase 2 SAT-3247 DMD Study
    Satellos Doses First Patient in Phase 2 SAT-3247 DMD Study

    12 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-12/satellos-announces-first-participant-dosed-in-phase-2-pediatric-study-of-sat-3247-for-duchenne-muscu

    PHARMIWEB
    12 Feb 2026
    Share Share
    Satellos Joins Guggenheim Biotech Summit 2026
    Satellos Joins Guggenheim Biotech Summit 2026

    10 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260210502722/en/Satellos-to-Participate-in-the-Guggenheim-Securities-Emerging-Outlook-Biotech-Summit-2026

    BUSINESSWIRE
    10 Feb 2026
    Share Share
    Satellos Completes $57.2M Public Offering In Us And Canada,
    Satellos Completes $57.2M Public Offering In Us And Canada,

    09 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260209211048/en/Satellos-Closes-US%2457.2-Million-Public-Offering-in-Canada-and-the-United-States-Including-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares

    BUSINESSWIRE
    09 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search